Huabang Pharmaceutical Group 1.5 skin drug tazarotene betamethasone cream entered the site for inspection this month

According to the public information, tazarotene betamethasone cream is a compound preparation of tazarotene and betamethasone, which is mainly used for the treatment of psoriasis It is developed by Huabang Yingtai, and has not been declared by other manufacturers After being approved, it will become an exclusive product In 2013, the market scale of psoriasis in sample hospitals was 84.86 million yuan, and the market share of Huabang Yingtai was 10%, the rest was occupied by foreign enterprises According to Shenyin Wanguo Research Report, the market sales of tazarotene betamethasone cream is expected to reach 100-200 million yuan It is worth noting that Warburg bond Yingtai's tazarotene betamethasone cream has been listed in the 76 major special varieties released by CDE As early as 2012, the product was included in the list of 100 key products of Chongqing pharmaceutical industry, with a total investment of 8 billion yuan Founded in September 1994, Huabang Pharmaceutical Co., Ltd is a pharmaceutical enterprise mainly engaged in the R & D, production and sales of skin and tuberculosis drugs At present, the company is in the stage of clinical application and research and development of more than 20 varieties, including three new drugs, palonosetron hydrochloride injection, linezolid, Halometasone, etc It is the core business medicine business department of Huabang Yingtai group (Shenzhen code 002004), a listed company Its headquarter is located next to the core happiness square of Liangjiang New District, Chongqing, covering an area of 260 mu Preparations and API products are sold to domestic and overseas markets, and have been the leading position in clinical dermatology in China for many years Huabang Yingtai is a first-line pesticide enterprise of domestic research and development Its main business is mainly pesticide, supplemented by medicine (skin medicine specialty).